Physical Activity after Cardiac EventS (PACES) - a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: study protocol for a randomised controlled trial
- PMID: 30286797
- PMCID: PMC6172802
- DOI: 10.1186/s13063-018-2923-x
Physical Activity after Cardiac EventS (PACES) - a group education programme with subsequent text-message support designed to increase physical activity in individuals with diagnosed coronary heart disease: study protocol for a randomised controlled trial
Abstract
Background: Coronary heart disease (CHD) represents approximately 13% of deaths worldwide and is the leading cause of death in the UK with considerable associated health care costs. After a CHD event, timely cardiac rehabilitation optimises patient outcomes. However, a high percentage of these services do not meet necessary performance indicators such as course length and follow-up attendance. Uptake of such services is only 50% in UK patients and support provided 12 months after an event is often limited. To delay and prevent further CHD events leading to hospitalisation, supplementary self-management strategies such as group education, are necessary.
Methods: This is a single-centre, randomised controlled trial (RCT) recruiting participants (n = 290) aged ≥18 years who are 12 to 48 months post diagnosis of a CHD-related cardiac event (myocardial infarction, angina and any other acute coronary syndrome). The study aims to implement a structured education programme, with text-message support over 12 months, and identify whether delivery of the programme, to individuals who have a history of a cardiac event, would be an effective and cost-effective strategy for increasing walking. The primary outcome, objectively measured average daily physical activity, specifically step count through walking activity, is assessed using the wrist-worn GENEActiv accelerometer at baseline, 6 and 12 months. Secondary outcomes at 12 months include cardiovascular risk factors such as smoking status, blood pressure, lipid profile, glycated haemoglobin (HbA1c), obesity, self-efficacy, quality of life, physical activity and physical function. Participants are randomised to either the control group receiving standard care and a physical activity information leaflet, or the intervention group whose partcipants receive the leaflet and are invited to attend two group-based structured education sessions. These encourage participants to adopt and maintain healthy behaviours and self-manage their lifestyle. They are delivered approximately 2 weeks apart by trained facilitators and reinforced via subsequent text-message support.
Discussion: To our knowledge, this is the first trial designed to assess the effectiveness of a group education programme 12 to 48 months after a CHD event diagnosis. If successful, the PACES programme could be translated into effective post-operative cardiac care and complement the current post-operative services available.
Trial registration: ISRCTN, ID: ISRCTN91163727 . The trial was registered on 27 February 2017.
Keywords: Cardiac rehabilitation; Coronary heart disease; Education; Physical activity; Randomised controlled trial; Self-management.
Conflict of interest statement
Ethics approval and consent to participate
The trial is sponsored by the University of Leicester (sponsor representative is Dr. Michelle Mueller; uolsponsor@le.ac.uk). Ethical approval was granted on 19 December 2016 by the West Midlands-Solihull National Research Ethics Committee (16/WM/0463) and the Health Research Authority. Written informed consent is provided by the participant before any study data are collected.
Consent for publication
Not applicable.
Competing interests
LYH, HD, SS, IH, DB, KK, TY, SC and MJD declare that they have no competing interests.
SS has acted as a consultant and speaker for Astra Zeneca, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Janssen, and Boehringer Ingelheim. He has received grants in support of implementation research from Janssen. He has served on advisory boards for, Novartis, Novo Nordisk, Sanofi-Aventis, Lilly, Merck Sharp & Dohme, Janssen, and Boehringer Ingelheim.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Figures
References
-
- World Health Organisation (WHO). Cardiovascular diseases (CVDs) Fact Sheet. 2017. Available from: https://www.who.int/mediacentre/factsheets/fs317/en/. Accessed 25 Oct 2017.
-
- British Heart Foundation (BHF) Coronary heart disease statistics. 2012.
-
- Townsend N, et al. Coronary heart disease statistics: a compendium of health statistics. London: British Heart Foundation; 2012.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
